Stay updated with breaking news from Gina fusaro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bristol Myers Squibb said on Thursday the injectable form of Opdivo, its blockbuster cancer drug, was found to be non-inferior in a late-stage trial to the approved intravenous form used in patients. ....
Bristol-Myers Squibb (BMY) Reports Phase 3 CheckMate -67T Trial of Subcutaneous Nivolumab Meets Co-Primary Endpoints streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
BMS's subcutaneous Opdivo measures up to infused version fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.
Subcutaneous Nivolumab Meets PK and ORR End Points in Pretreated Advanced or Metastatic ccRCC onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.